When Amber of BNN pressed Simple Simon to share his 'plan for how a Tilray would enter the US - all a flustered Simon could say was 'we'll figure out a way'
A comprehensive, strategic plan if there ever was one.<br />
While other companies prepared such plans - and readied for US entry - Simple Simon and his merry band were going to give it some thought and figure something out
Now, the best they could do was raise $250 million so they could see if they could buy a MSO.
Never mind that rescheduling doesn't legalize cannabis - and that as a foreign cannabis LP, Tilray is in no way guaranteed access to the Us market - maybe in a couple of years.
The funniest part - in true Simple Simon fashion? Such arrangements could have been in place - and many of the lesser MSOs could have been had at bargain prices.
With Simple Simon waiting until AFTER rescheduling - the announcement has increased the asking price of such MSOs - and Tilray investors will once again overpay for some loser, near bankrupt MSO - with Simple Simon desperate to enter the US at any cost.
The $30 million a year man - Simple Simon will no doubt collect some more performance bonuses